H. Lee Moffitt Cancer Center and Research Institute: Prostatic Neoplasms trials

The registry lists 28 Prostatic Neoplasms studies with H. Lee Moffitt Cancer Center and Research Institute as lead sponsor. 1 are open to participants now and 4 have results posted.

Early Phase 1 2Phase 1 2Phase 2 11Phase 3 1No phase 14(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test ScoresRecruitingNCT03495427Phase 2/3
• Focal Prostate Radio-Frequency AblationCompletedNCT02328807Not applicableResults posted
• Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSATerminatedNCT01531205Phase 2Results posted
• Phase II Clinical Trial of Purified Isoflavones in Prostate Cancer: Comparing Safety, EffectivenessCompletedNCT01036321Phase 2Results posted
• PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive TreatmentCompletedNCT00694551Not applicableResults posted
• Exploring Men s Prostate Cancer Genetic Risk PerceptionsCompletedNCT06764992
• Adaptive Androgen Deprivation and Docetaxel in Metastatic Castration Sensitive Prostate CancerActive, not recruitingNCT06734130Phase 2
• Non-Invasive Biomarkers in Prostate Cancer Disease ManagementSuspendedNCT06144619
• Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate CancerActive, not recruitingNCT05751941Phase 2
• First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate CancerActive, not recruitingNCT05189457Phase 2
• Comparing Pre-Anesthesia Evaluation Via Telemedicine Versus in Person for Surgical Patients at Moffitt Cancer CenterCompletedNCT05065944
• Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery EmbolizationActive, not recruitingNCT04879940Phase 2
• Clinical Trial of Green Tea Catechins in Men on Active SurveillanceActive, not recruitingNCT04300855Phase 2
• Single Arm Trial of Preoperative Stereotactic Body Radiation Therapy (SBRT) for T3a or Gleason Grade Group 4 Prostate CancerWithdrawnNCT03748719Not applicable
• Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation TherapyCompletedNCT03543189Phase 1/2
• Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate CancerActive, not recruitingNCT03511196Early Phase 1
• Biobank for African American Prostate Cancer Research in FloridaCompletedNCT03232411
• Feasibility Study of Ultrasound Elastography Detecting Prostate CancerCompletedNCT03077126Not applicable
• Assess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223CompletedNCT02981797
• Validation Study on the Impact of Decipher® Testing - VANDAAM StudyActive, not recruitingNCT02723734
• Dose Escalation Study of Preoperative SBRT for High Risk Prostate CancerCompletedNCT02572284Phase 1
• Adaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate CancerCompletedNCT02415621Early Phase 1
• Navigator Guided e-Psychoeducational InterventionCompletedNCT02186444
• Pilot Study on Focal Prostate Radio-Frequency AblationCompletedNCT01423006Not applicable
• Decision Making in Unaffected First-Degree Relatives of Prostate Cancer PatientsCompletedNCT00815750Not applicable
• The Specific Role of Isoflavones in Reducing Prostate Cancer RiskCompletedNCT00617617Phase 2
• Isoflavones & Lycopene in Localized Prostate Ca:Prior to Radical ProstatectomyCompletedNCT00042731Not applicable
• A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate CancerTerminatedNCT00006371Phase 2